By Nigam Arora & Dr. Natasha Arora 517% Gain Congratulations! Arena Pharmaceuticals (ARNA), a biotech associated with marijuana, has received a $100 per share all-cash offer from Pfizer (PFE). ARNA is long from the original Arora buy signal from $16.20. At a $100 cash offer, it represents a gain of 517%. Arena has
By Nigam Arora & Dr. Natasha Arora The Monumental Bill The top Senate Democrats led by Senator Schumer are introducing a new marijuana bill with great fanfare. Schumer said, “This is monumental because at long last we are taking stops in the Senate to right the wrongs of the failed
Deadline You make good financial decisions. Today is the last day to take advantage of the double special offer. The time to act is now. Astounding Gains The profits in Marijuana Model Portfolio have been astounding. There are 11 stocks in the portfolio. Look at these gains that were available
Deadline You make good financial decisions. The deadline to take advantage of the double special offer is only three days away. The time to act is now. Astounding Gains The profits in Marijuana Model Portfolio have been astounding. There are 11 stocks in the portfolio. Look at these gains that
Astounding Gains The profits in Marijuana Model Portfolio have been astounding. There are 11 stocks in the portfolio. Look at these gains that were available in about a month based on the Arora signals given. ARNA 6% CGC 95% CRLBF 62% CRON 118% CURLF 35% GRWG 57% GTBIF 52% GWPH
Astounding Gains The profits in Marijuana Model Portfolio have been astounding. There are 11 stocks in the portfolio. Look at these gains in about a month as of this writing. There is likely to be a sharp pullback and that is why our call has been to take profits. ARNA 6%
There is a big opportunity in marijuana stocks. Millions will be made. There is high risk in individual marijuana stocks. For those who do not want to take high risk, a better way is to use an ETF. If you acted on the Arora signal to buy marijuana ETF
How would you like to wake up to a 50% gain? This is exactly what happened today to the paying subscribers to The Arora Report. GW Pharmaceuticals (GWPH) which is in The Arora Report Marijuana Model Portfolio received a buyout offer from Jazz Pharmaceuticals (JAZZ). The offer is at a
The U.S. Food and Drug Administration has thrown a big impediment in the way of marijuana investors. Before discussing the FDA’s move, let’s build some background with the help of a chart. Please click here for a chart showing segmented money flows in 16 popular marijuana stocks. Note the following: • Smart
Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market